Artiva Biotherapeutics Financials - Benzinga

Artiva Biotherapeutics Inc

ARTVNASDAQ

Trade with Public

Trade with Public

$8.61

0.172.01%

At close: Sep 18, 5:00 PM EST

$8.60

-0.01-0.12%

After Hours: Sep 18, 5:20 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Artiva Biotherapeutics Financials

Artiva Biotherapeutics (ARTV) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Artiva Biotherapeutics Q1 EPS $(0.95) Misses $(0.89) Estimate

Artiva Biotherapeutics (NASDAQ:ARTV) reported quarterly losses of $(0.95) per share which missed the analyst consensus estimate of $(0.89) by 6.74 percent. This is a 14.46 percent decrease over losses of $(0.83) per

Benzinga Newsdesk

PRO
Artiva Biotherapeutics Q4 EPS $(0.84) Misses $(0.83) Estimate

Artiva Biotherapeutics (NASDAQ:ARTV) reported quarterly losses of $(0.84) per share which missed the analyst consensus estimate of $(0.83) by 1.45 percent. This is a 27.27 percent decrease over losses of $(0.66) per

Benzinga Newsdesk

US Stocks Mixed; NY Manufacturing Activity Dips In December

Avi Kapoor

PRO
Artiva Biotherapeutics Q3 EPS $(0.88), Inline

Benzinga Newsdesk

Gold Falls 1%; SLB Posts Better-Than-Expected Q3 Earnings

Avi Kapoor

Dow Gains Over 100 Points; American Express Increases 2025 Forecast

Avi Kapoor